ZFP36 expression impairs glioblastoma cell lines viability and invasiveness by targeting multiple signal transduction

Tommaso Selmi1, Andrea Martello, Tatiana Vignudelli

  • 1Dipartimento di Scienze Biomediche, Sezione di Chimica Biologica, Università di Modena e Reggio Emilia, Modena, Italy.

Insights

The ZFP36 gene family, involved in RNA regulation, shows tumor suppressor activity. Its expression impairs glioblastoma cell viability and invasiveness, suggesting therapeutic potential.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • RNA binding proteins of the TIS11/TTP gene family regulate target stability.
  • Inactivation or altered expression of these proteins is linked to cancer, suggesting tumor suppressor roles.

Purpose of the Study:

  • To identify new targets of ZFP36.
  • To investigate the effect of ZFP36 ectopic expression on glioblastoma cell viability and invasiveness.
  • To explore the therapeutic potential of compounds that induce TIS11/TTP gene expression.

Main Methods:

  • Identification of new ZFP36 targets (PIM-1, PIM-3, XIAP).
  • Ectopic expression of ZFP36 in glioblastoma cell lines.
  • Assessment of cell viability and invasiveness.
  • Analysis of affected transduction pathways.
  • Treatment with compounds inducing TIS11/TTP gene expression.

Main Results:

  • ZFP36 targets PIM-1, PIM-3, and XIAP were identified.
  • Ectopic ZFP36 expression reduced glioblastoma cell viability and invasiveness.
  • ZFP36 interfered with multiple signal transduction pathways.
  • Compounds inducing TIS11/TTP genes mimicked the effects of ZFP36 expression.

Conclusions:

  • ZFP36 exhibits tumor suppressor activity in glioblastoma.
  • ZFP36 impacts glioblastoma cell behavior through various signaling pathways.
  • Inducing TIS11/TTP gene expression represents a potential therapeutic strategy for glioblastoma.